Maurizio Cutolo is an expert in Rheumatology at Ospedale Policlinico San Martino (Italy). As of October 2026, ScienceLeadR ranks Maurizio Cutolo in the top 1% of experts worldwide for Arthritis, Autoimmune Diseases and Scleroderma, Systemic. Maurizio Cutolo has authored 1,087 publications, the most recent in 2026, and is an investigator in 12 clinical trials. SLR score: 3,946 (community average: 125). How the SLR is computed.

LeadR Profile

3 946 ScienceLeadR Reputation 3946
Network Map

Rheumatology

Subspecialties: Dermatology - Immunology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1984 - 2026

Source: PubMed

University of Genoa

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1087

Citations

Citations: 57 770 1st author: 210 Last author: 346 Unique author: 46


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Educational efficacy of an onsite training course in improving theoretical and practical skills in nailfold videocapillaroscopy among first-year rheumatology trainees: experience from the Italian Society of Rheumatology Inaugural Residential Program.
PMID 42860915 — rheumatology, rheumatic diseases
Reumatismo20260
Elderly-onset rheumatoid arthritis versus polymyalgia rheumatica: A systematic review and meta-analysis on pathophysiology, diagnosis and clinical progression.
PMID 42858918 — bias, arthritis, aged, arthritis, rheumatoid, diagnosis, therapeutics, polymyalgia rheumatica, synovitis, autoimmunity
Autoimmun Rev20260
Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.
PMID 42736088 — sclerosis, drug development, pharmaceutical preparations, rheumatic diseases, therapeutics, physical exertion, scleroderma, systemic
Ann Rheum Dis20260
Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.
PMID 42663235 — registries, sclerosis, mortality, lung, neoplasms, arthritis, rheumatic diseases, therapeutics, smoking, scleroderma, systemic
Arthritis Rheumatol20260
Primary and Secondary Raynaud: A Scientific Statement From the American Heart Association.
PMID 42639644 — quality of life, systemic vasculitis, heart, connective tissue, signs and symptoms, microscopic angioscopy, therapeutics, tissues, scleroderma, systemic
Circulation Top journal20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 5
Phase 2 4
Phase 4 2
N/A 1

By status:

Completed 11
Unknown 1

By type:

Interventional 11
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 1
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 24

LeadR Networks

Main global connection map